Fully Integrated AAV Engineering and Gene Therapy Company

We are a biotechnology company creating a new class of targeted gene therapies for debilitating and life-threatening genetic disorders in both central nervous system (CNS) and non-CNS indications.

Current gene therapy approaches have shown dramatic efficacy in several rare diseases but are hindered by imprecise targeting. The inability to selectively transduce specific cells and tissues effectively drives administration of higher doses and resulting safety liabilities. We are addressing these concerns with our proprietary adeno-associated virus (AAV) engineering platform that generates capsids optimized to target specific tissues and cells in the disease organ while limiting transduction of tissues and cells not relevant to the target disease.
Through our next-generation AAV platform combined with cargo development and state-of-the-art manufacturing, we are tackling monogenetic and sporadic CNS and non-CNS disorders that have previously been challenging to address.

Recent News

Capsida Biotherapeutics Unveils Next-Generation Gene Therapy Manufacturing

July 22, 2021

New 15,000 square-foot facility in Thousand Oaks will enable industry leading end-to-end gene therapy manufacturing capability THOUSAND OAKS, Calif., July 22, 2021 – Capsida Biotherapeutics Inc., a fully integrated biotechnology company creating a new class of targeted adeno-associated virus (AAV) gene therapies for patients with debilitating and life-threatening genetic disorders, today announced the opening of … Read More

Read More

CRISPR Therapeutics and Capsida Biotherapeutics Announce Strategic Collaboration to Develop Gene-Edited Therapies for Amyotrophic Lateral Sclerosis and Friedreich’s Ataxia

June 15, 2021

Collaboration leverages expertise and capabilities of both companies towards developing life-changing treatments for severe neurological diseases ZUG, Switzerland, CAMBRIDGE, Mass., and THOUSAND OAKS, Calif. – June 15, 2021 — CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on developing transformative gene-based medicines for serious diseases, and Capsida Biotherapeutics Inc., a biotechnology company dedicated to developing … Read More

Read More

Capsida Appoints Swati Tole, M.D., as Chief Medical Officer

May 12, 2021

Capsida Biotherapeutics Inc., a biotechnology company creating a new class of targeted gene therapies using its next-generation adeno-associated virus (AAV) engineering and cargo development platform, today announced the appointment of Swati Tole, M.D., as the Company’s first chief medical officer.

Read More

Capsida Biotherapeutics Debuts with $140 Million of Capital

April 29, 2021

Versant Ventures and Westlake Village BioPartners today announced the emergence from stealth mode of Capsida Biotherapeutics Inc., a biotechnology company using an adeno-associated virus (AAV) engineering and cargo development platform to develop tissue-targeted gene therapies for multiple types of diseases.

Read More

Join the Team

Scientist/Sr. Scientist – Protein Engineering
Capsida Biotherapeutics | Thousand Oaks, CA

Apply Now

Research Associate/Sr. Research Associate – AAV Engineering & HTS
Capsida Biotherapeutics | Thousand Oaks, CA

Apply Now

Research Associate, Analytical Development, Molecular Assays
Capsida Biotherapeutics | Thousand Oaks, CA

Apply Now

Research Assoociate/Sr. Research Associate, AAV Engineering
Capsida Biotherapeutics | Thousand Oaks, CA

Apply Now

Scientist/Sr. Scientist – Analytical Development Assays
Capsida Biotherapeutics | Thousand Oaks, CA

Apply Now

Automation Scientist
Capsida Biotherapeutics | Thousand Oaks, CA

Apply Now

Sr. Scientist – AAV Engineering, HTS
Capsida Biotherapeutics | Thousand Oaks, CA

Apply Now

Sr. Instrumentation Technician
Capsida Biotherapeutics | Thousand Oaks, CA

Apply Now

Software Developer/Engineer
Capsida Biotherapeutics | Thousand Oaks, CA

Apply Now

Scientist/Senior Scientist – Downstream AAV Process Development
Capsida Biotherapeutics | Thousand Oaks, CA

Apply Now

Research Assistant/Senior Research Assistant – Gene Therapy
Capsida Biotherapeutics | Thousand Oaks, CA

Apply Now

Principal Scientist – Cell Line Development
Capsida Biotherapeutics | Thousand Oaks, CA

Apply Now

Scientist/Senior Scientist – Preclinical Gene Therapy
Capsida Biotherapeutics | Thousand Oaks, CA

Apply Now

Scientist/Senior Scientist – In Vitro Assay Development
Capsida Biotherapeutics | Thousand Oaks, CA

Apply Now

Scientist/Senior Scientist – AAV Immunology
Capsida Biotherapeutics | Thousand Oaks, CA

Apply Now

Contact